Effects of the selective μ1-opioid receptor antagonist, naloxonazine, on cocaine-induced conditioned place preference and locomotor behavior in rats

Neuroscience Letters

Volumn 332, Issue 3, 2002, Pages 159-162

  Rademacher, David J ^a   Steinpreis, Rhea E ^b  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Cocaine; Conditioned place preference; Locomotion; Naloxonazine; Opioid receptors; Reward

Indexed keywords

COCAINE; MU OPIATE RECEPTOR ANTAGONIST; NALOXONAZINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; LOCOMOTION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD; TASK PERFORMANCE;

ANIMALS; COCAINE; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MOTOR ACTIVITY; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; REWARD;

EID: 0037044702     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00950-3     Document Type: Article

References (20)

1. Brown E.E., Finlay J.M., Wong J.T.F., Damsa G., Fibiger H.C. Behavioral and neurochemical interactions between cocaine and buprenorphine: implications for the pharmacotherapy of cocaine abuse. J. Pharmacol. Exp. Ther. 256:1991;119-126.
2. Carroll M.E., Lac S.T., Walker M.J., Kragh R., Newman T. Effects of naltrexone on intravenous self-administration in rats during food satiation and deprivation. J. Pharmacol. Exp. Ther. 238:1986;1-7.
3. Damianopoulos E.N., Carey R.J. Evidence for N-methyl-D-aspartate receptor mediation of cocaine induced corticosterone release and cocaine conditioned stimulant effects. Behav. Brain Res. 68:1995;219-228.
4. De Vry J., Donselaar I., Van Ree J.M. Food deprivation and acquisition of intravenous cocaine self-administration in rats: effects of naltrexone and haloperidol. J. Pharmacol. Exp. Ther. 251:1989;735-740.
5. 1- but not by a δ-opioid receptor antagonist in alcohol- preferring rats. Eur. J. Pharmacol. 304:1996;7-13.
6. Jasinski D.R., Martin W.R., Haertzen C.A. The human pharmacology and abuse potential of N-allyl noroxymorphone (naltrexone). J. Pharmacol. Exp. Ther. 157:1967;420-426.
7. Johnson N., Pasternak G.W. Binding of 3H-naloxonazine to rat brain membranes. Mol. Pharmacol. 26:1984;477-483.
8. Koob G.F., Pettit H.O., Ettenberg A., Bloom F.E. Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat. J. Pharmacol. Exp. Ther. 229:1984;481-486.
9. Mann P.E., Pasternak G.W., Hahn E.F., Curreri G., Lubin E., Bodnar R.J. Comparison of effects of chronic administration of naloxone and naloxonazine upon food intake and maintenance of body weight in rats. Neuropharmacology. 27:1988;349-355.
10. Matsuzawa S., Suzuki T., Misawa M., Nagase H. Different roles of μ-, δ-, and κ-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress. Eur. J. Pharmacol. 368:1999;9-16.
11. Matthes H.W.D., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dollé P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature. 383:1996;819-823.
12. Mello N.K., Mendelson J.H., Bree M.P., Lukas S.E. Buprenorphine suppresses cocaine self-administration by rhesus monkeys. Science. 245:1989;859-862.
13. Mitchem L.D., Kruschel C.K., Dallman E., Anders K.A., Czapiga M., Panos J.J., Steinpreis R.E. The effects of the naltrexone implant on rodent social interactions and cocaine-induced conditioned place preference. Pharmacol. Biochem. Behav. 62:1999;97-102.
14. Mucha R.F., Herz A. Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology. 86:1985;274-280.
15. Negus S.S., Henriksen S.J., Mattox A., Pasternak G.W., Portoghese P.S., Takemori A.E., Weinger M.B., Koob G.F. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats. J. Pharmacol. Exp. Ther. 265:1993;1245-1252.
16. Phillips A.G., Le Piane F.G. Reward produced by microinjection of (D-Ala), Met-enkephalinamide into the ventral tegmental area. Behav. Brain Res. 5:1982;225-229.
17. Rademacher D.J., Anders K.A., Riley M.G., Nesbitt J.T., Steinpreis R.E. Determination of the place conditioning and locomotor effects of amperozide in rats: a comparison with cocaine. Exp. Clin. Psychopharmacol. 8:2000;434-443.
18. Ukai M., Holtzman S.G. Effects of beta-funaltrexamine on ingestive behaviors in the rat. Eur. J. Pharmacol. 153:1988;161-165.
19. Vocci F.J., Sorer H. Pharmacotherapies for the treatment of opioid dependence. J. Health Care Poor Underserved. 3:1992;109-124.
20. Wise R.A. Drug-activation of brain reward pathways. Drug Alcohol Depend. 51:1998;13-22.